Corning to highlight newest products in 3D cell culture portfolio at SLAS2021

Corning Incorporated will highlight its latest technologies that support the advancement of 3D cell culture, automation, and drug discovery at this year's virtual Society for Laboratory Automation and Screening (SLAS) conference on Jan. 25 through 27.

Now more than ever, tools used to facilitate scale-up, reproducibility, and consistency of 3D cell culture are helping enable critical research needed to solve the industry's most pressing problems.

Corning will share the newest products in its 3D cell culture portfolio, including Matrigel® matrix-3D plates, which can provide a more consistent, ready-to-use cell culture format to support organoid and spheroid culture models and reduce workflow steps. Also featured is Corning® Matrigel matrix for organoid culture, a vialed solution that is validated to support growth and differentiation of organoid culture and is also qualified to form stable "3D dome" structures commonly used in organoid culture.

New Corning Elplasia® plates, which will be highlighted at the conference, feature microcavity technology for high volume spheroid production, and Corning 3D clear tissue clearing reagent allows for rapid and easy imaging of 3D cultures. These new products are designed to address high throughput screening and imaging for 3D cell culture, while maintaining reproducibility and consistency - common barriers to widespread adoption of 3D workflows.

Corning Life Sciences experts - including John M. Tobin, vice president and general manager- will be available to discuss how these tools are being used to study and develop treatments for a variety of diseases and in other critical areas of research. Applications for these tools include drug screening, cancer and stem cell biology, 3D tissue engineering, immunology, immuno-oncology, and personalized medicine.

In addition, Corning will showcase its automation and disease modeling solutions used in diagnostic workflows, research and vaccine development, as well as efforts related to the COVID-19 response. These include lung organoids generated using Corning Matrigel matrix and air-liquid interface models produced with Transwell® and Falcon® permeable supports. The development of complex 3D models like these can aid in studying virus infectivity, helping to identify the best ways to treat and prevent disease. Other helpful tools, such as Corning robotic tips and assay microplates, are used in diagnostic workflows, and upstream solutions in bioproduction support vaccine development.

Corning and its customers will also offer several presentations during the virtual SLAS meeting including:


  • Monday, Jan. 25, 2021 12:30 - 1 p.m. EST
    Tutorial Session: "Gut-in-a-Dish" Model for Developing Personalized Therapies for Chronic Inflammatory Diseases
    Presented by: Soumita Das, assistant professor, Dept. of Pathology, chief scientific director, HUMANOID, University of California San Diego
  • Wednesday, Jan. 27, 2021
    1:30 - 2 p.m. EST
    Tutorial Session: High throughput Applications with Organoids
    Presented by: Hilary Sherman, senior scientist, Corning Life Sciences

To learn more about how Corning is helping enable advancements in 3D cell culture with innovative technologies and workflow solutions, view the company's digital booth #11 and schedule a virtual meeting with a member of the Corning executive team.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
You might also like... ×
Characterization of B-cell receptor repertoires in COVID-19 patients